Background Aortic root enlargement (ARE) may be an important adjunct to aortic valve
replacement (AVR) to prevent patient-prosthesis mismatch and facilitate future valve-in …

Background Transcatheter aortic valve-in-valve (VIV) procedure is a safe alternative to
conventional reoperation for bioprosthetic dysfunction. Balloon-expandable valve (BEV) and …

Background Redo surgical aortic valve replacement (redo SAVR) and valve‐in‐valve
transcatheter aortic valve replacement (ViV TAVR) are the two treatment strategies available …

Abstract Purpose of Review This review aims to summarize data regarding bioprosthetic
valve fracture (BVF), a novel technique that involves fracturing the surgical valve sewing ring …

Despite the widespread adoption of valve-in-valve transcatheter aortic valve replacement
(VIV-TAVR) for patients with failed aortic bioprosthesis, the effectiveness of this treatment for …

Objectives To demonstrate safety, feasibility and short‐term clinical outcomes after
transcatheter aortic valve‐in‐valve (ViV) implantation under local anesthesia without …

Background This study investigated the extent and nature of cardiac morbidity and cause of
mortality in patients with Mitroflow structural valve deterioration (SVD). Methods A …

Introduction: Aortic valve bioprostheses ring fracture in valve-in-valve procedures has shown
low complication rates and presents as an option in the treatment of patients at high risk for …

While transcatheter valve‐in‐valve (ViV) implantation may reduce the number of lifetime
surgical reinterventions in some patients with congenital heart disease, in other patients the …

Introduction: Transcatheter aortic valve-in-valve implantation (TAVI-ViV) can be associated
with unfavorable hemodynamic outcomes. This study aimed to estimate the prevalence …